Overview Financials News + Filings Key Docs Charts Ownership Insiders |
uniQure N.V. (QURE)
|
Add to portfolio |
|
|
Price: |
$34.88
| | Metrics |
OS: |
47.6
|
M
| |
|
|
Market cap: |
$1.66
|
B
| |
|
|
Net cash:
|
$50.6
|
M
| |
$1.06
|
per share
|
EV:
|
$1.61
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($138)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 106.5 | 524.0 | 37.5 | 7.3 | 11.3 | 13.1 | 25.1 | 10.6 |
Revenue growth | -79.7% | 1296.8% | 415.2% | -35.5% | -13.9% | -47.8% | 137.3% | 72.3% |
Cost of goods sold | 118.6 | 71.2 | 75.9 | 59.1 | 47.5 | 47.2 | 43.6 | 32.7 |
Gross profit | -12.2 | 452.8 | -38.4 | -51.8 | -36.2 | -34.1 | -18.5 | -22.2 |
Gross margin | -11.4% | 86.4% | -102.4% | -712.1% | -320.6% | -260.0% | -73.8% | -209.5% |
Selling, general and administrative | 125.1 | 113.9 | 86.1 | 67.0 | 53.3 | 51.6 | 52.8 | 43.7 |
Research and development | 197.6 | 143.5 | 122.4 | 94.7 | 74.8 | 72.2 | 72.5 | 59.1 |
General and administrative | 70.1 | 57.6 | 43.6 | 33.4 | 28.0 | 26.9 | 25.0 | |
EBIT | -138.8 | 317.5 | -127.7 | -118.6 | -92.3 | -66.1 | -70.0 | -62.7 |
EBIT margin | -130.4% | 60.6% | -340.5% | -1629.0% | -817.8% | -504.7% | -279.1% | -592.3% |
Pre-tax income | -128.3 | 332.8 | -141.4 | -124.2 | -83.1 | -79.5 | -72.2 | -83.3 |
Income taxes | -1.5 | 3.2 | -16.4 | 0.0 | 0.2 | -0.2 | 1.1 | -1.2 |
Tax rate | 1.1% | 1.0% | 11.6% | 0.0% | | 0.3% | | 1.4% |
Net income | -126.8 | 329.6 | -125.0 | -124.2 | -83.3 | -79.3 | -73.4 | -82.1 |
Net margin | -119.1% | 62.9% | -333.3% | -1705.8% | -738.2% | -604.7% | -292.3% | -776.0% |
|
Diluted EPS | ($2.71) | $7.04 | ($2.81) | ($3.11) | ($2,337.39) | ($2,937.28) | ($2.93) | ($3.72) |
Shares outstanding (diluted) | 46.7 | 46.8 | 44.5 | 40.0 | 0.0 | 0.0 | 25.0 | 22.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|